DSpace Repository

Treating Triple Negative Breast Cancer Cells with Erlotinib Plus a Select Antioxidant overcomes Drug Resistance by Targeting Cancer Cell Heterogeneity.

Files in this item

This item appears in the following Collection(s)

Search DSpace


Browse

My Account